Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001012975-25-000601·Dimension Capital I, L.P.
Schedule 13G ownership disclosure
Monte Rosa Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 61225M102
Event date: 2024-05-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adam Goulburn
Shares: 4,757,563 · Class: 7.7%
- Zavain Dar
Shares: 4,757,563 · Class: 7.7%
- Nan Li
Shares: 4,757,563 · Class: 7.7%
- Dimension Management, L.P.
Shares: 4,757,563 · Class: 7.7%
- Dimension Capital I GP, LLC
Shares: 4,757,563 · Class: 7.7%
- Dimension Management GP, LLC
Shares: 4,757,563 · Class: 7.7%
- Dimension Capital I, L.P.
Shares: 4,757,563 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001012975-25-000601
- Form type
- SCHEDULE 13G
- Filer
- Dimension Capital I, L.P.
- CIK
- CIK 1939538
- Filed
- Oct 03, 2025
- Reporting period
- May 16, 2024
- Description
- Schedule 13G beneficial ownership